- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Brucellosis Vaccines will have significant change from previous year. By the most conservative estimates of global Brucellosis Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 11 million in 2020. Over the next five years the Brucellosis Vaccines market will register a 3.8% CAGR in terms of revenue, the global market size will reach US$ 13 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Brucellosis Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
S19 Vaccine
RB51 Vaccine Strain
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Cattle
Sheep
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Jinyu
Colorado Serum
Boehringer Ingelheim
Biogenesis-Bago
Vetal Company
CZ Veterinaria
SYVA Laboratorios
Indian Immunologicals
Qilu
Tecnovax
Hester Biosciences
Zoetis
Onderstepoort Biological
Instituto Rosenbusch
Ceva Sante Animale
Calier & Biologicos Laverlam
Biovet
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Brucellosis Vaccines Consumption 2016-2026
2.1.2 Brucellosis Vaccines Consumption CAGR by Region
2.2 Brucellosis Vaccines Segment by Type
2.2.1 S19 Vaccine
2.2.2 RB51 Vaccine Strain
2.2.3 Others
2.3 Brucellosis Vaccines Sales by Type
2.3.1 Global Brucellosis Vaccines Sales Market Share by Type (2016-2021)
2.3.2 Global Brucellosis Vaccines Revenue and Market Share by Type (2016-2021)
2.3.3 Global Brucellosis Vaccines Sale Price by Type (2016-2021)
2.4 Brucellosis Vaccines Segment by Application
2.4.1 Cattle
2.4.2 Sheep
2.4.3 Others
2.5 Brucellosis Vaccines Sales by Application
2.5.1 Global Brucellosis Vaccines Sale Market Share by Application (2016-2021)
2.5.2 Global Brucellosis Vaccines Revenue and Market Share by Application (2016-2021)
2.5.3 Global Brucellosis Vaccines Sale Price by Application (2016-2021)
3 Global Brucellosis Vaccines by Company
3.1 Global Brucellosis Vaccines Sales Market Share by Company
3.1.1 Global Brucellosis Vaccines Sales by Company (2019-2021)
3.1.2 Global Brucellosis Vaccines Sales Market Share by Company (2019-2021)
3.2 Global Brucellosis Vaccines Revenue Market Share by Company
3.2.1 Global Brucellosis Vaccines Revenue by Company (2019-2021)
3.2.2 Global Brucellosis Vaccines Revenue Market Share by Company (2019-2021)
3.3 Global Brucellosis Vaccines Sale Price by Company
3.4 Global Manufacturers Brucellosis Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Brucellosis Vaccines Product Location Distribution
3.4.2 Players Brucellosis Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Brucellosis Vaccines by Region
4.1 Global Brucellosis Vaccines by Region
4.1.1 Global Brucellosis Vaccines Sales by Region
4.1.2 Global Brucellosis Vaccines Revenue by Region
4.2 Americas Brucellosis Vaccines Sales Growth
4.3 APAC Brucellosis Vaccines Sales Growth
4.4 Europe Brucellosis Vaccines Sales Growth
4.5 Middle East & Africa Brucellosis Vaccines Sales Growth
5 Americas
5.1 Americas Brucellosis Vaccines Sales by Country
5.1.1 Americas Brucellosis Vaccines Sales by Country (2016-2021)
5.1.2 Americas Brucellosis Vaccines Revenue by Country (2016-2021)
5.2 Americas Brucellosis Vaccines Sales by Type
5.3 Americas Brucellosis Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Brucellosis Vaccines Sales by Region
6.1.1 APAC Brucellosis Vaccines Sales by Region (2016-2021)
6.1.2 APAC Brucellosis Vaccines Revenue by Region (2016-2021)
6.2 APAC Brucellosis Vaccines Sales by Type
6.3 APAC Brucellosis Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Brucellosis Vaccines by Country
7.1.1 Europe Brucellosis Vaccines Sales by Country (2016-2021)
7.1.2 Europe Brucellosis Vaccines Revenue by Country (2016-2021)
7.2 Europe Brucellosis Vaccines Sales by Type
7.3 Europe Brucellosis Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Brucellosis Vaccines by Country
8.1.1 Middle East & Africa Brucellosis Vaccines Sales by Country (2016-2021)
8.1.2 Middle East & Africa Brucellosis Vaccines Revenue by Country (2016-2021)
8.2 Middle East & Africa Brucellosis Vaccines Sales by Type
8.3 Middle East & Africa Brucellosis Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Brucellosis Vaccines Distributors
10.3 Brucellosis Vaccines Customer
11 Global Brucellosis Vaccines Market Forecast
11.1 Global Brucellosis Vaccines Forecast by Region
11.1.1 Global Brucellosis Vaccines Forecast by Regions (2021-2026)
11.2.2 Global Brucellosis Vaccines Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Brucellosis Vaccines Forecast by Type
11.7 Global Brucellosis Vaccines Forecast by Application
12 Key Players Analysis
12.1 Jinyu
12.1.1 Jinyu Company Information
12.1.2 Jinyu Brucellosis Vaccines Product Offered
12.1.3 Jinyu Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Jinyu Main Business Overview
12.1.5 Jinyu Latest Developments
12.2 Colorado Serum
12.2.1 Colorado Serum Company Information
12.2.2 Colorado Serum Brucellosis Vaccines Product Offered
12.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Colorado Serum Main Business Overview
12.2.5 Colorado Serum Latest Developments
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Company Information
12.3.2 Boehringer Ingelheim Brucellosis Vaccines Product Offered
12.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Boehringer Ingelheim Main Business Overview
12.3.5 Boehringer Ingelheim Latest Developments
12.4 Biogenesis-Bago
12.4.1 Biogenesis-Bago Company Information
12.4.2 Biogenesis-Bago Brucellosis Vaccines Product Offered
12.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Biogenesis-Bago Main Business Overview
12.4.5 Biogenesis-Bago Latest Developments
12.5 Vetal Company
12.5.1 Vetal Company Company Information
12.5.2 Vetal Company Brucellosis Vaccines Product Offered
12.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Vetal Company Main Business Overview
12.5.5 Vetal Company Latest Developments
12.6 CZ Veterinaria
12.6.1 CZ Veterinaria Company Information
12.6.2 CZ Veterinaria Brucellosis Vaccines Product Offered
12.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 CZ Veterinaria Main Business Overview
12.6.5 CZ Veterinaria Latest Developments
12.7 SYVA Laboratorios
12.7.1 SYVA Laboratorios Company Information
12.7.2 SYVA Laboratorios Brucellosis Vaccines Product Offered
12.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 SYVA Laboratorios Main Business Overview
12.7.5 SYVA Laboratorios Latest Developments
12.8 Indian Immunologicals
12.8.1 Indian Immunologicals Company Information
12.8.2 Indian Immunologicals Brucellosis Vaccines Product Offered
12.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Indian Immunologicals Main Business Overview
12.8.5 Indian Immunologicals Latest Developments
12.9 Qilu
12.9.1 Qilu Company Information
12.9.2 Qilu Brucellosis Vaccines Product Offered
12.9.3 Qilu Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Qilu Main Business Overview
12.9.5 Qilu Latest Developments
12.10 Tecnovax
12.10.1 Tecnovax Company Information
12.10.2 Tecnovax Brucellosis Vaccines Product Offered
12.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Tecnovax Main Business Overview
12.10.5 Tecnovax Latest Developments
12.11 Hester Biosciences
12.11.1 Hester Biosciences Company Information
12.11.2 Hester Biosciences Brucellosis Vaccines Product Offered
12.11.3 Hester Biosciences Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Hester Biosciences Main Business Overview
12.11.5 Hester Biosciences Latest Developments
12.12 Zoetis
12.12.1 Zoetis Company Information
12.12.2 Zoetis Brucellosis Vaccines Product Offered
12.12.3 Zoetis Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Zoetis Main Business Overview
12.12.5 Zoetis Latest Developments
12.13 Onderstepoort Biological
12.13.1 Onderstepoort Biological Company Information
12.13.2 Onderstepoort Biological Brucellosis Vaccines Product Offered
12.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Onderstepoort Biological Main Business Overview
12.13.5 Onderstepoort Biological Latest Developments
12.14 Instituto Rosenbusch
12.14.1 Instituto Rosenbusch Company Information
12.14.2 Instituto Rosenbusch Brucellosis Vaccines Product Offered
12.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Instituto Rosenbusch Main Business Overview
12.14.5 Instituto Rosenbusch Latest Developments
12.15 Ceva Sante Animale
12.15.1 Ceva Sante Animale Company Information
12.15.2 Ceva Sante Animale Brucellosis Vaccines Product Offered
12.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Ceva Sante Animale Main Business Overview
12.15.5 Ceva Sante Animale Latest Developments
12.16 Calier & Biologicos Laverlam
12.16.1 Calier & Biologicos Laverlam Company Information
12.16.2 Calier & Biologicos Laverlam Brucellosis Vaccines Product Offered
12.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Calier & Biologicos Laverlam Main Business Overview
12.16.5 Calier & Biologicos Laverlam Latest Developments
12.17 Biovet
12.17.1 Biovet Company Information
12.17.2 Biovet Brucellosis Vaccines Product Offered
12.17.3 Biovet Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Biovet Main Business Overview
12.17.5 Biovet Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Brucellosis Vaccines Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of S19 Vaccine
Table 3. Major Players of RB51 Vaccine Strain
Table 4. Major Players of Others
Table 5. Global Brucellosis Vaccines Sales by Type (2016-2021) & (M Doses)
Table 6. Global Brucellosis Vaccines Sales Market Share by Type (2016-2021)
Table 7. Global Brucellosis Vaccines Revenue by Type (2016-2021) & ($ million)
Table 8. Global Brucellosis Vaccines Revenue Market Share by Type (2016-2021)
Table 9. Global Brucellosis Vaccines Sale Price by Type (2016-2021)
Table 10. Global Brucellosis Vaccines Sales by Application (2016-2021) & (M Doses)
Table 11. Global Brucellosis Vaccines Sales Market Share by Application (2016-2021)
Table 12. Global Brucellosis Vaccines Value by Application (2016-2021)
Table 13. Global Brucellosis Vaccines Revenue Market Share by Application (2016-2021)
Table 14. Global Brucellosis Vaccines Sale Price by Application (2016-2021)
Table 15. Global Brucellosis Vaccines Sales by Company (2019-2021) & (M Doses)
Table 16. Global Brucellosis Vaccines Sales Market Share by Company (2019-2021)
Table 17. Global Brucellosis Vaccines Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Brucellosis Vaccines Revenue Market Share by Company (2019-2021)
Table 19. Global Brucellosis Vaccines Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Brucellosis Vaccines Producing Area Distribution and Sales Area
Table 21. Players Brucellosis Vaccines Products Offered
Table 22. Brucellosis Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Brucellosis Vaccines Sales by Region (2016-2021) (M Doses)
Table 26. Global Brucellosis Vaccines Sales Market Share by Region (2016-2021)
Table 27. Global Brucellosis Vaccines Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Brucellosis Vaccines Revenue Market Share by Region (2016-2021)
Table 29. Americas Brucellosis Vaccines Sales by Country (2016-2021) & (M Doses)
Table 30. Americas Brucellosis Vaccines Sales Market Share by Country (2016-2021)
Table 31. Americas Brucellosis Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Brucellosis Vaccines Revenue Market Share by Country (2016-2021)
Table 33. Americas Brucellosis Vaccines Sales by Type (2016-2021) & (M Doses)
Table 34. Americas Brucellosis Vaccines Sales Market Share by Type (2016-2021)
Table 35. Americas Brucellosis Vaccines Sales by Application (2016-2021) & (M Doses)
Table 36. Americas Brucellosis Vaccines Sales Market Share by Application (2016-2021)
Table 37. APAC Brucellosis Vaccines Sales by Region (2016-2021) & (M Doses)
Table 38. APAC Brucellosis Vaccines Sales Market Share by Region (2016-2021)
Table 39. APAC Brucellosis Vaccines Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Brucellosis Vaccines Revenue Market Share by Region (2016-2021)
Table 41. APAC Brucellosis Vaccines Sales by Type (2016-2021) & (M Doses)
Table 42. APAC Brucellosis Vaccines Sales Market Share by Type (2016-2021)
Table 43. APAC Brucellosis Vaccines Sales by Application (2016-2021) & (M Doses)
Table 44. APAC Brucellosis Vaccines Sales Market Share by Application (2016-2021)
Table 45. Europe Brucellosis Vaccines Sales by Country (2016-2021) & (M Doses)
Table 46. Europe Brucellosis Vaccines Sales Market Share by Country (2016-2021)
Table 47. Europe Brucellosis Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Brucellosis Vaccines Revenue Market Share by Country (2016-2021)
Table 49. Europe Brucellosis Vaccines Sales by Type (2016-2021) & (M Doses)
Table 50. Europe Brucellosis Vaccines Sales Market Share by Type (2016-2021)
Table 51. Europe Brucellosis Vaccines Sales by Application (2016-2021) & (M Doses)
Table 52. Europe Brucellosis Vaccines Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Brucellosis Vaccines Sales by Country (2016-2021) & (M Doses)
Table 54. Middle East & Africa Brucellosis Vaccines Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Brucellosis Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Brucellosis Vaccines Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Brucellosis Vaccines Sales by Type (2016-2021) & (M Doses)
Table 58. Middle East & Africa Brucellosis Vaccines Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Brucellosis Vaccines Sales by Application (2016-2021) & (M Doses)
Table 60. Middle East & Africa Brucellosis Vaccines Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Brucellosis Vaccines
Table 62. Key Application and Potential Industries of Brucellosis Vaccines
Table 63. Key Challenges of Brucellosis Vaccines
Table 64. Key Trends of Brucellosis Vaccines
Table 65. Brucellosis Vaccines Distributors List
Table 66. Brucellosis Vaccines Customer List
Table 67. Global Brucellosis Vaccines Sales Forecast by Region (2021-2026) & (M Doses)
Table 68. Global Brucellosis Vaccines Consumption Market Forecast by Region
Table 69. Global Brucellosis Vaccines Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Brucellosis Vaccines Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Brucellosis Vaccines Sales Forecast by Country (2021-2026) & (M Doses)
Table 72. Americas Brucellosis Vaccines Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Brucellosis Vaccines Sales Forecast by Region (2021-2026) & (M Doses)
Table 74. APAC Brucellosis Vaccines Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Brucellosis Vaccines Sales Forecast by Country (2021-2026) & (M Doses)
Table 76. Europe Brucellosis Vaccines Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Brucellosis Vaccines Sales Forecast by Country (2021-2026) & (M Doses)
Table 78. Middle East & Africa Brucellosis Vaccines Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Brucellosis Vaccines Sales Forecast by Type (2021-2026) & (M Doses)
Table 80. Global Brucellosis Vaccines Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Brucellosis Vaccines Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Brucellosis Vaccines Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Brucellosis Vaccines Sales Forecast by Application (2021-2026) & (M Doses)
Table 84. Global Brucellosis Vaccines Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Brucellosis Vaccines Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Brucellosis Vaccines Revenue Market Share Forecast by Application (2021-2026)
Table 87. Jinyu Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. Jinyu Brucellosis Vaccines Product Offered
Table 89. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 90. Jinyu Main Business
Table 91. Jinyu Latest Developments
Table 92. Colorado Serum Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Colorado Serum Brucellosis Vaccines Product Offered
Table 94. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 95. Colorado Serum Main Business
Table 96. Colorado Serum Latest Developments
Table 97. Boehringer Ingelheim Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Boehringer Ingelheim Brucellosis Vaccines Product Offered
Table 99. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 100. Boehringer Ingelheim Main Business
Table 101. Boehringer Ingelheim Latest Developments
Table 102. Biogenesis-Bago Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Biogenesis-Bago Brucellosis Vaccines Product Offered
Table 104. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 105. Biogenesis-Bago Main Business
Table 106. Biogenesis-Bago Latest Developments
Table 107. Vetal Company Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Vetal Company Brucellosis Vaccines Product Offered
Table 109. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 110. Vetal Company Main Business
Table 111. Vetal Company Latest Developments
Table 112. CZ Veterinaria Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. CZ Veterinaria Brucellosis Vaccines Product Offered
Table 114. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 115. CZ Veterinaria Main Business
Table 116. CZ Veterinaria Latest Developments
Table 117. SYVA Laboratorios Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. SYVA Laboratorios Brucellosis Vaccines Product Offered
Table 119. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 120. SYVA Laboratorios Main Business
Table 121. SYVA Laboratorios Latest Developments
Table 122. Indian Immunologicals Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. Indian Immunologicals Brucellosis Vaccines Product Offered
Table 124. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 125. Indian Immunologicals Main Business
Table 126. Indian Immunologicals Latest Developments
Table 127. Qilu Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. Qilu Brucellosis Vaccines Product Offered
Table 129. Qilu Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 130. Qilu Main Business
Table 131. Qilu Latest Developments
Table 132. Tecnovax Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Tecnovax Brucellosis Vaccines Product Offered
Table 134. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 135. Tecnovax Main Business
Table 136. Tecnovax Latest Developments
Table 137. Hester Biosciences Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 138. Hester Biosciences Brucellosis Vaccines Product Offered
Table 139. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 140. Hester Biosciences Main Business
Table 141. Hester Biosciences Latest Developments
Table 142. Zoetis Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 143. Zoetis Brucellosis Vaccines Product Offered
Table 144. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 145. Zoetis Main Business
Table 146. Zoetis Latest Developments
Table 147. Onderstepoort Biological Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 148. Onderstepoort Biological Brucellosis Vaccines Product Offered
Table 149. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 150. Onderstepoort Biological Main Business
Table 151. Onderstepoort Biological Latest Developments
Table 152. Instituto Rosenbusch Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 153. Instituto Rosenbusch Brucellosis Vaccines Product Offered
Table 154. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 155. Instituto Rosenbusch Main Business
Table 156. Instituto Rosenbusch Latest Developments
Table 157. Ceva Sante Animale Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 158. Ceva Sante Animale Brucellosis Vaccines Product Offered
Table 159. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 160. Ceva Sante Animale Main Business
Table 161. Ceva Sante Animale Latest Developments
Table 162. Calier & Biologicos Laverlam Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 163. Calier & Biologicos Laverlam Brucellosis Vaccines Product Offered
Table 164. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 165. Calier & Biologicos Laverlam Main Business
Table 166. Calier & Biologicos Laverlam Latest Developments
Table 167. Biovet Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 168. Biovet Brucellosis Vaccines Product Offered
Table 169. Biovet Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 170. Biovet Main Business
Table 171. Biovet Latest Developments
List of Figures
Figure 1. Picture of Brucellosis Vaccines
Figure 2. Brucellosis Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Brucellosis Vaccines Sales Growth Rate 2016-2026 (M Doses)
Figure 7. Global Brucellosis Vaccines Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Brucellosis Vaccines Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of S19 Vaccine
Figure 10. Product Picture of RB51 Vaccine Strain
Figure 11. Product Picture of Others
Figure 12. Global Brucellosis Vaccines Sales Market Share by Type in 2020
Figure 13. Global Brucellosis Vaccines Revenue Market Share by Type (2016-2021)
Figure 14. Brucellosis Vaccines Consumed in Cattle
Figure 15. Global Brucellosis Vaccines Market: Cattle (2016-2021) & (M Doses)
Figure 16. Brucellosis Vaccines Consumed in Sheep
Figure 17. Global Brucellosis Vaccines Market: Sheep (2016-2021) & (M Doses)
Figure 18. Brucellosis Vaccines Consumed in Others
Figure 19. Global Brucellosis Vaccines Market: Others (2016-2021) & (M Doses)
Figure 20. Global Brucellosis Vaccines Sales Market Share by Application (2016-2021)
Figure 21. Global Brucellosis Vaccines Revenue Market Share by Application in 2020
Figure 22. Brucellosis Vaccines Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Brucellosis Vaccines Revenue Market Share by Company in 2020
Figure 24. Global Brucellosis Vaccines Sales Market Share by Regions (2016-2021)
Figure 25. Global Brucellosis Vaccines Revenue Market Share by Region in 2020
Figure 26. Americas Brucellosis Vaccines Sales 2016-2021 (M Doses)
Figure 27. Americas Brucellosis Vaccines Revenue 2016-2021 ($ Millions)
Figure 28. APAC Brucellosis Vaccines Sales 2016-2021 (M Doses)
Figure 29. APAC Brucellosis Vaccines Revenue 2016-2021 ($ Millions)
Figure 30. Europe Brucellosis Vaccines Sales 2016-2021 (M Doses)
Figure 31. Europe Brucellosis Vaccines Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Brucellosis Vaccines Sales 2016-2021 (M Doses)
Figure 33. Middle East & Africa Brucellosis Vaccines Revenue 2016-2021 ($ Millions)
Figure 34. Americas Brucellosis Vaccines Sales Market Share by Country in 2020
Figure 35. Americas Brucellosis Vaccines Revenue Market Share by Country in 2020
Figure 36. Americas Brucellosis Vaccines Sales Market Share by Type in 2020
Figure 37. Americas Brucellosis Vaccines Sales Market Share by Application in 2020
Figure 38. United States Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Brucellosis Vaccines Sales Market Share by Region in 2020
Figure 43. APAC Brucellosis Vaccines Revenue Market Share by Regions in 2020
Figure 44. APAC Brucellosis Vaccines Sales Market Share by Type in 2020
Figure 45. APAC Brucellosis Vaccines Sales Market Share by Application in 2020
Figure 46. China Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Brucellosis Vaccines Sales Market Share by Country in 2020
Figure 53. Europe Brucellosis Vaccines Revenue Market Share by Country in 2020
Figure 54. Europe Brucellosis Vaccines Sales Market Share by Type in 2020
Figure 55. Europe Brucellosis Vaccines Sales Market Share by Application in 2020
Figure 56. Germany Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Brucellosis Vaccines Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Brucellosis Vaccines Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Brucellosis Vaccines Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Brucellosis Vaccines Sales Market Share by Application in 2020
Figure 65. Egypt Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Brucellosis Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
